CenterBook Partners LP Has $4.58 Million Stake in Clarivate PLC $CLVT

CenterBook Partners LP grew its position in Clarivate PLC (NYSE:CLVT) by 81.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,369,972 shares of the company’s stock after purchasing an additional 616,490 shares during the quarter. CenterBook Partners LP owned about 0.21% of Clarivate worth $4,576,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Goldman Sachs Group Inc. grew its position in shares of Clarivate by 65.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 882,528 shares of the company’s stock valued at $2,948,000 after purchasing an additional 350,129 shares during the last quarter. BW Gestao de Investimentos Ltda. grew its position in shares of Clarivate by 51.7% in the fourth quarter. BW Gestao de Investimentos Ltda. now owns 4,345,321 shares of the company’s stock valued at $14,513,000 after purchasing an additional 1,480,300 shares during the last quarter. Geode Capital Management LLC grew its position in Clarivate by 1.1% during the fourth quarter. Geode Capital Management LLC now owns 7,048,518 shares of the company’s stock worth $23,549,000 after buying an additional 78,367 shares in the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake in Clarivate during the fourth quarter worth approximately $71,000. Finally, LSV Asset Management grew its position in Clarivate by 25.6% during the fourth quarter. LSV Asset Management now owns 2,647,900 shares of the company’s stock worth $8,844,000 after buying an additional 540,400 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.

Clarivate Stock Up 1.0%

NYSE CLVT opened at $2.44 on Tuesday. The business has a fifty day moving average price of $2.53 and a two-hundred day moving average price of $2.77. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.84 and a quick ratio of 0.84. Clarivate PLC has a fifty-two week low of $1.66 and a fifty-two week high of $4.77. The stock has a market capitalization of $1.56 billion, a PE ratio of -11.60 and a beta of 1.37.

Clarivate (NYSE:CLVT) last released its earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The firm had revenue of $585.50 million during the quarter, compared to analysts’ expectations of $569.50 million. During the same period in the prior year, the company earned $0.14 earnings per share. The company’s quarterly revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Equities analysts expect that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Royal Bank Of Canada reduced their price target on Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 25th. Barclays reduced their price target on Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a research report on Wednesday, February 25th. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research report on Friday, March 27th. Citigroup reduced their price target on Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a research report on Wednesday, March 4th. Finally, Wall Street Zen raised Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Five analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $3.22.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.